Loading clinical trials...
Loading clinical trials...
This study is to examine whether radical prostatectomy can impact survival and quality-of-life in men with oligo-metastatic prostate cancer.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Fudan University
Collaborators
NCT07004582 · Prostate Cancer, Prostate Cancer Metastatic Disease, and more
NCT06849544 · Prostate Cancer Surgery, Prostate Cancer Metastatic Disease
NCT07115914 · Prostate Cancer (Adenocarcinoma), Prostate Cancer (Diagnosis), and more
NCT05327465 · Androgen Deprivation Therapy, Prostate Cancer, and more
NCT06165302 · Prostate Cancer Metastatic, Prostate Cancer
Zhongshan Hospital, Fudan University
Shanghai, Shanghai Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions